Salisbury Foundation Trust

FOI_5692

Internal Reference Number: FOI_5692

Date Request Received: 05/06/2020 10:19:06

Date Request Replied To: 03/07/2020 09:16:35

This response was sent via: By Email

Request Summary: Metastatic Non-small-cell lung cancer and Squamous Cell Non-small-cell lung cancer

Request Category: Private Individuals

 
Question Number 1:
Within your health trust how many patients are currently [within the past 3 months] being treated with the following:
Afatinib
Atezolizumab monotherapy or combination
Brigatinib
Ceretinib
Crizotinib
Docetaxel mono or combination
Erlotinib
Gefitinib
Gemcitabine
Nitendanib + docetaxel
 
Answer To Question 1:
Q. Within your health trust how many patients are currently [within the past 3 months] being treated for metastatic Non-small-cell lung cancer (NSCLC) with the following:
Afatinib 2
Atezolizumab monotherapy or combination 5
Brigatinib 0
Ceretinib 0
Crizotinib 0
Docetaxel mono or combination 2
Erlotinib 0
Gefitinib 3
Gemcitabine 1
Nitendanib + docetaxel 1
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2021 Salisbury NHS Foundation Trust
Trust Values